Abstract
Redox signaling is a critical component of cell signaling pathways that are involved in the regulation of cell growth, metabolism, hormone signaling, immune regulation and variety of other physiological functions. Peroxiredoxin (Prx) is a family of thiol-based peroxidase that acts as a regulator of redox signaling. Members of Prx family can act as antioxidants and chaperones. Sulfiredoxin (Srx) is an antioxidant protein that exclusively reduces over-oxidized typical 2-Cys Prx. Srx has different affinities for individual Prx and it also catalyzes the deglutathionylation of variety of substrates. Individual component of the Srx-Prx system plays critical role in carcinogenesis by modulating cell signaling pathways involved in cell proliferation, migration and metastasis. Expression levels of individual component of the Srx-Prx axis have been correlated with patient survival outcome in multiple cancer types. This review will summarize the molecular basis of differences in the affinity of Srx for individual Prx and the role of individual component of the Srx-Prx system in tumor progression and metastasis. This enhanced understanding of molecular aspects of Srx-Prx interaction and its role in cell signal transduction will help define the Srx-Prx system as a future therapeutic target in human cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 150-159 |
| Number of pages | 10 |
| Journal | Cancer Letters |
| Volume | 366 |
| Issue number | 2 |
| DOIs | |
| State | Published - Oct 1 2015 |
Bibliographical note
Funding Information:This work was partially supported by the National Institutes of Health, with funding from the National Cancer Institute grant number R00-CA149144 and a pilot project of NIGMS P20GM103486 to Q. Wei
Publisher Copyright:
© 2015 Elsevier Ireland Ltd.
Keywords
- Oncogene
- Peroxiredoxin
- Redox signaling
- Sulfiredoxin
- Tumorigenesis
ASJC Scopus subject areas
- Oncology
- Cancer Research
